Orthobiologics Market Analysis 2019 to 2026 report published by “Fortune Business Insights”. According to report Global Orthobiologics Market to Rise At 4.5% CAGR and reach market value $8,261.6 Million Million by 2026. Orthobiologics Industry report anlayzes Market for Orthobiologics by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), By Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and Regional Forecast 2019-2026.
Get Sample “Orthobiologics Market Research – Global Forecast till 2026” Report
Major Orthobiologics Companies covered in the market report include Stryker, Zimmer Biomet, Sea Spine, Bioventus, RTI Surgical Holdings, Inc., Musculoskeletal Transplant Foundation, and Wright Medical Group N.V.
Orthobiologics Market Analysis From 2020 To 2026:
Orthobiologics acts as healing agent in the post-operative period of orthopedic injuries, which is why its demand is rising around the world. On account of deploying efficient methods to use orthobiologics and developing newer products, Medtronic has emerged as the leading company in the global market. In 2018, Medtronic received FDA clearance for Infuse Bone Graft for spine implants.
Global Orthobiologics Market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Orthobiologics Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. Regionally, this report categorizes the production, apparent consumption, export and import of Orthobiologics in North America, Europe, China, Japan, Southeast Asia and India.
According to a recent survey by the Centers for Disease Control and Prevention, over 30 million people in the U.S. are affected by osteoarthritis. This accounts for nearly 10% of the overall population in the U.S., which has led to an increasing emphasis on orthobiologics. This is mainly due to the fact that orthobiologics play a massive role in treating orthopedic disorders. Recently, orthobiologics has been used for newer treatment methods in spinal fusion, dental, maxillofacial, cartilage repair, knee arthroscopies, and other such disorders.
The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Orthobiologics Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
With a strong market portfolio, Medtronic will possibly be the leading company throughout the forecast period. According to Fortune Business Insights it accounted for the highest market share in 2018. Currently, Medtronic and Sanofi are dominating the global orthobiologics market.
Originating as the first generation of orthobiologics, viscosupplements were by far the most widely used product type. Viscosupplements dominated the global orthobiologics market in 2018 wherein, they accounted for a share of 32.1%. Viscosupplements are extensively used in the treatment of knee osteoarthritis, which is one of the major problems among the geriatric population. Recent marketing approvals have favored viscosupplements, thereby creating a potential for further growth.
Regional Analysis:
This report focuses on Orthobiologics Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The orthobiologics market in North America was valued at US$ 2,326.2 Mn in 2018 and is likely to dominate throughout the forecast period. Recent business strategies adopted by orthobiologics companies in the U.S. have been integral to the growth of this market. Furthermore, the adoption of orthobiologics is boosted by favorable health reimbursement policies in the region. According to Fortune Business Insights, high prevalence of degenerative bone diseases may boost the orthobiologics market in North America during 2019-2026.
The orthobiologics market in Europe is likely to hold the second-largest share in the global market. The increasing use of orthobiologics in Europe can be attributed to recent market approval for Cingal, which is a highly efficient viscosupplement. Asia Pacific is expected to register the highest CAGR during the forecast period, mainly resulting from an increasing demand for viscosupplements in India and increase in number of standalone orthopedic clinics.
What is the scope of the report?
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Table Of Content:
1 Market Overview
1.1 Orthobiologics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Orthobiologics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Orthobiologics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Orthobiologics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Orthobiologics Manufacturer Market Share in 2018
3.3.2 Top 6 Orthobiologics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Orthobiologics Market Analysis by Regions
4.1 Global Orthobiologics Sales, Revenue and Market Share by Regions
4.1.1 Global Orthobiologics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Orthobiologics Revenue and Market Share by Regions (2014-2019)
4.2 North America Orthobiologics Sales and Growth Rate (2014-2019)
4.3 Europe Orthobiologics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Orthobiologics Sales and Growth Rate (2014-2019)
4.5 South America Orthobiologics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Orthobiologics Sales and Growth Rate (2014-2019)
5 North America Orthobiologics by Country
5.1 North America Orthobiologics Sales, Revenue and Market Share by Country
5.1.1 North America Orthobiologics Sales and Market Share by Country (2014-2019)
5.1.2 North America Orthobiologics Revenue and Market Share by Country (2014-2019)
5.2 United States Orthobiologics Sales and Growth Rate (2014-2019)
5.3 Canada Orthobiologics Sales and Growth Rate (2014-2019)
5.4 Mexico Orthobiologics Sales and Growth Rate (2014-2019)
8 South America Orthobiologics by Country
8.1 South America Orthobiologics Sales, Revenue and Market Share by Country
8.1.1 South America Orthobiologics Sales and Market Share by Country (2014-2019)
8.1.2 South America Orthobiologics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Orthobiologics Sales and Growth Rate (2014-2019)
8.3 Argentina Orthobiologics Sales and Growth Rate (2014-2019)
8.4 Colombia Orthobiologics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Orthobiologics by Countries
9.1 Middle East and Africa Orthobiologics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Orthobiologics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Orthobiologics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Orthobiologics Sales and Growth Rate (2014-2019)
9.3 Turkey Orthobiologics Sales and Growth Rate (2014-2019)
9.4 Egypt Orthobiologics Sales and Growth Rate (2014-2019)
9.5 Nigeria Orthobiologics Sales and Growth Rate (2014-2019)
10 Orthobiologics Market In Developing Conutries
11 South America Orthobiologics Market Analysis by Countries
12 Competitive Landscape
Continued…
LIST OF TABLES:
Table 1 Orthobiologics Industry Synopsis, 2017 – 2026
Table 2 Global Orthobiologics Market Estimates And Forecast, 2017 – 2026, (USD Million)
Table 3 Global Orthobiologics Market By Region, 2017 – 2026, (USD Million)
Table 4 Global Orthobiologics Market By Type, 2017 – 2026, (USD Million)
Table 5 Global Orthobiologics Market By Key Players, 2017 – 2026, (USD Million)
Table 6 Global Orthobiologics Market By Country, 2017 – 2026, (USD Million)
Table 7 Global Orthobiologics Market By Distribution Channel, 2017 – 2026, (USD Million)
Table 8 Global Orthobiologics Market By End User, 2017 – 2026, (USD Million)
Continued…
LIST OF FIGURES:
FIGURE 1 Research Process Of MRFR
FIGURE 2 Top-Down & Bottom-Up Approach
FIGURE 3 Market Dynamics
FIGURE 4 Impact Analysis: Market Drivers
FIGURE 5 Impact Analysis: Market Restraints
FIGURE 6 Porter’s Five Forces Analysis
FIGURE 7 Value Chain Analysis
Continued…
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245